Kristina Forslind

07-aug-202318-aug-2023

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.

Ajeganova S, Andersson M, Forslind K, Gjertsson I, Nyhäll-Wåhlin BM, Svensson B, Hafström I.BMC Rheumatol. 2023 Aug 7;7(1):23. doi: 10.1186/s41927-023-00347-6.PMID: 37550762

24-maj-202324-maj-2023

Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage.

Li T, Ge C, Krämer A, Sareila O, Leu Agelii M, Johansson L, Forslind K, Lönnblom E, Yang M, Xu B, Li Q, Cheng L, Bergström G, Fernandez G, Kastbom A, Rantapää-Dahlqvist S, Gjertsson I, Holmdahl R.Ann Rheum Dis. 2023 Jun;82(6):799-808. doi: 10.1136/ard-2022-223633. Epub 2023 Mar 1.PMID: 36858822

24-maj-202324-maj-2023

Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain-a 5-year follow-up study.

Eberhard A, Rydell E, Forslind K, Bergman S, Mandl T, Olofsson T, Jacobsson LTH, Turesson C.Arthritis Res Ther. 2023 Feb 27;25(1):29. doi: 10.1186/s13075-023-03015-9.PMID: 36849881

30-dec-202208-feb-2023

Erosion-free rheumatoid arthritis: clinical and conceptional implications-a BARFOT study.

Svensson B, Andersson MLE, Gjertsson I, Hafström I, Ajeganova S, Forslind K.BMC Rheumatol. 2022 Dec 30;6(1):88. doi: 10.1186/s41927-022-00317-4.PMID: 36581910

22-sep-202218-aug-2023

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria.

Leu Agelii M, Hafström I, Svensson B, Ajeganova S, Forslind K, Andersson M, Gjertsson I.Open Access Rheumatol. 2022 Sep 22;14:187-194. doi: 10.2147/OARRR.S372724. eCollection 2022.PMID: 36172258 Free PMC article.

01-sep-202229-nov-2022

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria.
Leu Agelii M, Hafström I, Svensson B, Ajeganova S, Forslind K, Andersson M, Gjertsson I.
Open Access Rheumatol. 2022 Sep 22;14:187-194. doi: 10.2147/OARRR.S372724. eCollection 2022.
PMID: 36172258

01-aug-202229-nov-2022

The effect of a tight control regime with monthly follow-up on remission rates and reported pain in early rheumatoid arthritis.
Aronsson M, Teleman A, Bergman S, Lindqvist E, Forslind K, Andersson MLE.
Musculoskeletal Care. 2022 Aug 12. doi: 10.1002/msc.1681. Online ahead of print.PMID: 35962485

28-jan-202228-jan-2022

Cone-beam computed tomography, a new low-dose three-dimensional imaging technique for assessment of bone erosions in rheumatoid arthritis: reliability assessment and comparison with conventional radiography – a BARFOT study.

Aurell Y, Andersson M, Forslind K. Scand J Rheumatol. 2018 May;47(3):173-177.

28-jan-202228-jan-2022

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff D, van Vollenhoven RF. RMD Open. 2016 Mar 1;2(1):e000197.

28-jan-202228-jan-2022

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson P, Cöster L, Forslind K, van Vollenhoven R, Heimbürger M. RMD Open. 2016 Jan 14;2(1):e000133.

28-jan-202228-jan-2022

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.

Forslind K, Svensson B. Scand J Rheumatol. 2016;45(2):99-102.

28-jan-202228-jan-2022

Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

van Vollenhoven RF, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Sasso EH, Hwang CC, Segurado OG, Geborek P. Arthritis Rheumatol. 2015 Nov;67(11):2855-60.

28-jan-202228-jan-2022

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH. J Rheumatol. 2015 Aug;42(8):1383-91.

28-jan-202228-jan-2022

Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial.

Levitsky A, Forslind K, van Vollenhoven RF; SWEFOT trial group. Scand J Rheumatol. 2015;44(5):348-53.

28-jan-202228-jan-2022

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study.

Andersson ML, Forslind K, Hafström I. Open Rheumatol J. 2015 Feb 3;9:8-15.